Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 313-322

  Prasad, Kailash ^a   Lee, Paul ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antioxidant reserve; Aortic chemiluminescence; Atherosclerosis; Cytokines; Hypercholesterolemia; Oxygen radicals; Pentoxifylline

Indexed keywords

ANTIOXIDANT; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PENTOXIFYLLINE; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BODY WEIGHT; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG MECHANISM; FEMALE; HYPERCHOLESTEROLEMIA; HYPERCHOLESTEROLEMIC ATHEROSCLEROSIS; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; BODY WEIGHT; BUTYLENE GLYCOLS; CHOLESTEROL, DIETARY; FEMALE; GLUCOSIDES; HYPERCHOLESTEROLEMIA; LIPIDS; LUMINESCENCE; MALONDIALDEHYDE; PENTOXIFYLLINE; RABBITS;

EID: 34248199903     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.034     Document Type: Article

References (69)

1. Prasad K., and Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of Vitamin E. Am Heart J 125 (1993) 958-973
2. Prasad K., Kalra J., and Lee P. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of probucol. Int J Angiol 3 (1994) 100-112
3. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation 85 (1992) 2338-2345
4. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99 (1999) 1355-1362
5. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179 (2005) 269-275
6. Prasad K. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132 (1997) 69-76
7. Croft K.D., Beilin L.J., Vandongen R., Rouse I., and Masarei J. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolemia. Atherosclerosis 83 (1990) 101-109
8. Bonavida B., Mencia-Huerta J.M., and Braquet P. Effect of platelet activating factor on monocyte activation and production of tumor necrosis factor. Int Arch Allergy Appl Immunol 88 (1989) 157-160
9. Pignol B., Henane S., Mencia-Huerta J.M., Rola-Pleszczynski M., and Braquet P. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin-1 (IL-1) release and synthesis by rat spleen adherent monocytes. Prostaglandins 33 (1987) 931-939
10. Madej A., Okopien B., Kowalski J., et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. Int J Clin Pharmacol Ther 36 (1998) 345-354
11. Zhao S.P., and Wu J. Fenofibrate reduces tumor necrosis factor-α serum concentration and adipocyte secretion of hypercholesterolemic rabbits. Clin Chim Acta 347 (2004) 145-150
12. Ascer E., Bertolami M.C., Venturinelli M.L., et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177 (2004) 161-166
13. Oubina M.P., de las Heras N., Cediel E., et al. Synergistic effect of angiotensin-converting enzyme (ACE and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits. Clin Sci (Lond) 105 (2003) 655-662
14. Han S.N., Leka L.S., Lichtenstein A.H., Ausman L.M., and Schaefer E.J. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 43 (2002) 445-452
15. Braquet P., Hosford D., Braquet M., Bourgain R., and Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol 88 (1989) 88-100
16. Wang Q., Doerschuk C.M., and Mizgerd J.P. Neutrophils in innate immunity. Semin Respir Crit Care Med 25 (2004) 33-41
17. Yuo A., Kitagawa S., Kasahara T., et al. Stimulation and priming of human neutrophils by interleukin-8: comparison with tumor necrosis factor and colony stimulating factors. Blood 78 (1991) 2708-2714
18. Ellis T.N., and Beaman B.L. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 112 (2004) 2-12
19. Watson D.A., Musher D.M., and Hamill R.J. Interferon-gamma and polymorphonuclear leukocytes. Ann Intern Med 109 (1988) 250-251
20. Gertzberg N., Neumann P., Rizzo V., and Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-α. Am J Physiol (Lung Cell Mol Physiol) 286 (2004) L37-L48
21. Nwariaku F.E., Liu Z., Zhu X., et al. NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 104 (2004) 3214-3220
22. Zabel P., Wolter D.T., Schonharting M.M., and Schade U.F. Oxpentifylline in endotoxemia. Lancet 2 (1989) 1474-1477
23. Thanhäuser A., Reiling N., Böhle A., et al. Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity. Immunology 80 (1993) 151-156
24. Sullivan G.W., Carper H.T., Novick Jr. W.J., and Mandell G.L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor-alpha on neutrophil function by pentoxifylline. Infect Immunol 56 (1988) 1722-1729
25. Neuner P., Klosner G., Schauer E., et al. Pentoxifylline in vivo down-regulates the release of IL-1B, IL-6, IL-8 and tumor necrosis factor-α by human peripheral blood mononuclear cells. Immunology 83 (1994) 262-267
26. Tsujino A., Nakamura T., Nishiura Y., et al. Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy. J Neuroimmunol 73 (1997) 191-196
27. Benbernou N., Esnault S., Potron G., and Guenounou M. Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol 25 Suppl. 2 (1995) S75-S79
28. McCarty M.F. The reported clinical utility of taurine in ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion. Med Hypotheses 53 (1999) 290-299
29. Adams Jr. J.G., Dhar A., Shukla S.D., and Silver D. Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury. J Vasc Surg 21 (1995) 742-748
30. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol and enterolactone. Int J Angiol 9 (2000) 220-225
31. Prasad K., Gupta J.B., Kalra J., et al. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28 (1996) 375-385
32. Kapoor R., and Prasad K. Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: effect of SOD and catalase. Circ Shock 43 (1994) 79-94
33. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
34. Holman R.L., McGill Jr. H.C., Strong J.P., and Geer J.C. Techniques for studying atherosclerotic lesions. Lab Invest 7 (1958) 42-47
35. Allen R.C., and Loose L.D. Phagocytic activation of luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun 69 (1976) 245-252
36. Kapoor R., and Prasad K. Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrahagic shock and reinfusion. Free Radic Biol Med 21 (1996) 609-618
37. Gornall A.G., Barawill C.J., and David M.M. Determination of serum proteins by means of biuret reaction. J Biol Chem 177 (1949) 751-766
38. Prasad K., Mantha S.V., Muir A.D., and Westcott N.D. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136 (1998) 367-375
39. Satapathy S.K., Garg S., Chauhan R., et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 1946-1952
40. Beykirch H., Reuter W., Voigt H., and Herrmann W. Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine-a comparison with pentoxifylline. Z Gesamte Inn Med 44 (1989) 77-79
41. Strano A., Davi G., Avellone G., Novo S., and Pinto A. Double-blind, crossover study of the clinical efficacy and hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35 (1984) 459-466
42. Wang T., Elam M.B., Forbes W.P., Zhong J., and Nakajima K. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication. Atherosclerosis 171 (2003) 337-342
43. Clemens M.R., and Ruess M. Effect of pentoxifylline on erythrocyte membrane and plasma lipids. Eur J Clin Pharmacol 41 (1991) 623-624
44. Lee T.M., Su S.F., Hwang J.J., et al. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication. Atherosclerosis 158 (2001) 471-476
45. Dezube B.J., Pardee A.B., Chapman B., et al. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 6 (1993) 787-794
46. Warren J.S., and Ward P.A. Oxidative injury to the vascular endothelium. Am J Med Sci 292 (1986) 97-103
47. Martin A., Foxall T., Blumberg J.B., and Meydani M. Vitamin E inhibits low density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol 17 (1997) 429-436
48. Chiu J.J., Wung B.S., Shyy J.Y., Hsieh H.J., and Wang D.L. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 17 (1997) 3570-3577
49. Lee P., and Prasad K. Suppression of oxidative stress as a mechanism of reduction of hypercholestolemic atherosclerosis by cyclooxygense inhibitors. Int J Angiol 12 (2003) 13-23
50. Shifow A.A., Naidu M.U., Kumar K.V., Prayag A., and Ratnakar K.S. Effect of pentoxifylline on cyclosporine-induced nephrotoxicity in rats. Indian J Exp Biol 38 (2000) 347-352
51. Vardareli E., Saricam T., Koken T., et al. The effect of alpha-tocopherol and pentoxifylline on ischemia-reperfusion-induced liver injury in rats. Hepatogastroenterology 45 (1998) 1505-1508
52. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 168 (1997) 117-123
53. Cadenas E., Varsavsky A.I., Boveris A., and Chance B. Oxygen or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J 198 (1981) 645-654
54. Cadenas E., Wefers H., and Sies H. Low level chemiluminescence of isolated hepatocytes. Eur J Biochem 119 (1981) 531-536
55. Cadenas E., and Sies H. Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide: relation to microsomal hemoproteins, oxygen dependence and lipid peroxidation. Eur J Biochem 124 (1982) 349-356
56. Prasad K., and Lee P. Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin. J Cardiovasc Pharmacol Ther 8 (2003) 61-69
57. Mantha S.V., Prasad M., Kalra J., and Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of Vitamin E in rabbits. Atherosclerosis 101 (1993) 135-144
58. Cadenas E., Boveris A., and Chance B. Low-level chemiluminescence of bovine heart submitochondrial particles. Biochem J 186 (1980) 659-667
59. Vessey D.A., and Lee K.-H. Inactivation of enzymes of the glutathione antioxidant system by treatment of cultured human keratinocytes with peroxides. J Invest Dermatol 100 (1993) 829-833
60. Park J.E., Yang J.H., Yoon S.J., et al. Lipid peroxidation-mediated cytotoxicity and DNA damage in U937 cells. Biochimie 84 (2002) 1199-1205
61. Fan J., and Watanabe T. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis. J. Atheroscler Thromb 7 (2000) 26-32
62. Kolodgie F.D., Katocs Jr. A.S., Largis E.E., et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 16 (1996) 1454-1464
63. Holm J., and Hansson G.K. Cellular and immunologic features of carotid artery disease in man and experimental animal models. Eur J Vasc Surg 4 (1990) 49-55
64. Friedman M., and Byers S.O. Observations concerning the evolution of atherosclerosis in the rabbit after cessation of cholesterol feeding. Am J Pathol 43 (1963) 349-359
65. Bocan T.M. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr Pharm Des 4 (1998) 37-52
66. American Heart Association. Heart disease and stroke statistics: 2004 update. Available at: http://americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf. Accessed January 15, 2004.
67. Vaccarino V., Parsons L., Every N.R., Barron H.V., and Krumholz H.M. Sex-based differences in early mortality after myocardial infarction. National registry of myocardial infarction 2 participants. N Engl J Med 341 (1999) 217-225
68. Roberts D.C., West C.E., Redgrave T.G., and Smith J.B. Plasma cholesterol concentration in normal and cholesterol-fed rabbits. Its variation and heritability. Atherosclerosis 19 (1974) 369-380
69. Holm P., Andersen H.L., Arroe G., and Stender S. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbit: role of the endothelium and mononuclear-endothelial cell interaction. Circulation 98 (1998) 2731-2737